Transplantation · 1991 · 46 citations · 0 references
MedicineEndocrinologySurgeryCell TherapyTransplant ImmunologyTransplant SurgeryDiabetes ManagementDiabetes MellitusPancreas TransplantationPancreatic EndocrinologyPancreatic HormonesTransplant PharmacologyIslet Cell EncapsulationIslet MicroenvironmentPancreas Graft FunctionPancreatic Islet BiologyPancreatic Islet Cell TransplantationPancreatic Islet CellsPancreatic Islet EngraftmentPancreatic Islet Physiology
Allogeneic islets obtained from Lewis rats were transplanted into diabetic BB/W rats with or without cyclosporine. In addition, these islets were encapsulated in alginate-poly L-lysine membranes and then transplanted into diabetic BB/W rats with or without immunosuppressive and/or antiinflammatory agents. The agents used were cyclosporine, dexamethasone, indomethacin (Ind), or a combination of these. Our results show that islets alone survived for 7 days, with or without CsA therapy. Encapsulated islets survived for 14.2 days, and this was extended by CsA, Dex, or CsA + Ind. Loss of encapsulated graft functions was associated with formation of a dense pericapsular infiltrate, which was inhibited by CsA, Dex, CsA + Ind, or CsA + Dex. In addition, the infiltrate was reduced in animals that had diabetes for long periods of time (greater than 5 months versus less than 1 month). Empty capsules also provoked this cellular response. Thus, encapsulation of islets resulted in slightly prolonged islet survival, which was further enhanced by immunosuppression.